The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
28
12, 2025
Why is omega-3 so important?
28
12, 2025
XRP Price Prediction: XRP to Soar as This Top Crypto Under $0.05 Eyes 5000% Rally
While the sentiment grows with regard to a possible positive breakout in the XRP pricing, expert investors continue to turn their attention to the best cryptocurrency to buy in prior to the full-scale bull market to take place. One top crypto, which has recently gained popularity with regard to mainstream industry attention is Mutuum Finance (MUTM). The project is priced under the $0.05 benchmark, accessible in a presale process, where Phase 6 is sold out 99%. Currently accumulating over $19.5 million, amidst a firmly developing ground for its rising popularity, MUTM has gained popularity regarding its utility-center strategy for both lending and borrowing operations associated with a full-fledged DeFi technological platform.
Experts continue to cultivate a sense of FOMO with regard to the possibility of a 5,000% breakout, which will propel MUTM prices likely to trade within the ranges of $2.50 from the current ranges below $0.05.
XRP Attempts Rebound
XRP is now stabilizing around the channel support and appears to be on course for a possible resurgence, thanks to buying momentum aimed at protecting this pivotal level of support. Technical analysts are of the view that should this level of demand remain in place, a correction towards the downward-sloping resistance line could potentially start to form in order to provide some short-term gains in this overall consolidation trend. XRP is establishing itself in a descending triangle and is now in a basing process, which remains favorable from a technical perspective so long as its major level of support below remains in place. The descending resistance appears to be an essential spot for traders to reach in order to start gaining traction.
For those investment minds searching for further opportunities in this market amidst XRP’s recovery, utility cryptos such as Mutuum Finance (MUTM) have also garnered interest.
$0.035 Altcoin– Last Chance to Buy
Mutuum Finance (MUTM) is rapidly emerging as one of the most prospective DeFi projects of 2025. Phase 6 tokens are currently more than 99% sold out with over 18,590 participants and $19.5M raised. The current token price remains at $0.035, providing an opportunity for purchasing before Phase 7 prices at $0.04, moving towards the launching price set at $0.06. As Phase 6 of MUTM is almost entirely sold out, it remains one of the last chances for purchasing at a discounted price before the next market bull run.
While speculative tokens are more focused on speculation, Mutuum Finance has set the score by adoption. As far as investors interested in adoption and appreciation are concerned, MUTM is one of the best cryptocurrency to buy and the top crypto in 2025.
Flexible Lending
Mutuum Finance has designed not one but two revolutionary lending solutions for growth and stability. Peer-to-Contract (P2C) gathers assets into a liquidity market where users get distributed mtTokens in a 1:1 ratio, enabling users to gain dynamic APYs through lending, ensuring guaranteed passive income. For less conventional or volatile tokens, Peer-to-Peer (P2P) lending contracts are offered.
Mutuum Finance (MUTM) is the best cryptocurrency to buy in the market with a price of less than $0.05 and has immense potential. As phase 6 is over 99% sold out, with $19.5M raised, and over 18,590+ holders, investors now also have the opportunity to purchase holdings at $0.035. Additionally, with immense predicted gains of 5,000% and the price target reaching around $2.50 per token, an investment of $2,000 will soon hit $100,000, making MUTM have asymmetrical growth. The presale opportunity is soon to be over, and smart investors won’t want to miss another bull market.
For more information about Mutuum Finance (MUTM) visit the links below:
Website: https://mutuum.com/
Linktree: https://linktr.ee/mutuumfinance
28
12, 2025
The supplements that may shorten men’s life expectancy
High levels of an amino acid common in concentration supplements may shorten men’s life expectancy, a new study finds, possibly helping explain the life expectancy gap between men and women.
28
12, 2025
The Promising Link Between Green Tea & Alzheimer’s, Explained
According to the authors of a 2022 study published in Nature Communications, Alzheimer’s disease occurs when tau protein clumps into fibrous tangles that spread between brain cells, leading to their death. However, they found that a molecule found in green tea, epigallocatechin gallate (EGCG), could help break apart the protein tangles associated with Alzheimer’s disease.
To study the actions of EGCG on these proteins, the team analyzed tau tangles from the brains of people who had Alzheimer’s. Using cryogenic electron microscopy, they demonstrated that EGCG is capable of binding to small openings in tau fibers, destabilizing and pulling them apart.
However, the researchers said that EGCG is not able to penetrate the brain very well, and it interacts with other proteins besides tau. They felt that if they could identify other molecules with similar action to EGCG that are able to pass into the brain more effectively, this could lead to promising new Alzheimer’s medications. They used computer modeling to look for molecules that might act in a similar manner while also being more effective at entering the brain. In both lab and tissue tests, several of these candidates untangled tau and limited new tau formation.
Could green tea help prevent Alzheimer’s?
While the 2022 study states that the EGCG present in green tea is not good at making its way into the brain where it’s needed, a 2025 study found in npj Science of Food suggests that drinking green tea may still be helpful when it comes to reducing your chances of developing dementia.
This study examined whether there was any link between green tea or coffee drinking and cerebral white matter lesions and hippocampal and total brain volumes. The scientists used people’s own self-reported consumption of these beverages and performed magnetic resonance imaging (MRI) to investigate cerebral white matter lesions, hippocampal volume, and total brain volume. After analyzing the data, they found that there was a correlation between higher green tea intake and fewer cerebral white matter lesions. Coffee, however, did not produce the same result.
Should you drink green tea to protect yourself from Alzheimer’s?
Given the quality of the evidence and high potential for benefit, as well as its good safety profile, green tea appears to be a worthwhile addition to your diet if you’re looking to preserve cognitive function and prevent dementia.
According to the experts at Cognitive Vitality, there are multiple studies showing that drinking green tea is linked with a lower risk of dementia and cognitive decline. Studies have also found that moderate green tea consumption, which they define as three to five cups per day, is safe with only mild side effects.
Green tea supplements at high doses, however, may lead to gastrointestinal problems, elevated liver enzymes, and sleep issues. Additionally, there are certain medications that may interact with green tea, including warfarin, anisindione, and dicumarol. Green tea can also deplete folic acid and interfere with iron absorption.
28
12, 2025
Risky Pattern Forms Despite Key Catalysts
Solana price crashed by over 40% this year, with its market capitalization plunging from a peak of $135 billion to the current $70 billion. This article explores the top reasons why the SOL price crashed and the potential catalysts for 2026.
Reasons Why Solana Price Plunged in 2025
There are a few key reasons why SOL price crashed this year. The main one is that the crash mirrored the performance of other cryptocurrencies, which plunged by double digits during the year.
Most importantly, the coin dropped as Solana meme coins erased the gains they made earlier this year and plunged. Data compiled by CoinGecko shows that the market cap of all Solana meme coins tumbled from over $25 billion in January to the current $5.4 billion.
Most of these meme coins have plummeted such that none has a market capitalization of over $1 billion. Official Trump, which soared in January, has seen its market valuation drop to $990 million today.
READ MORE: Dogecoin Price Crashed 63% in 2025 — What’s Ahead in 2026?
The falling Solana meme coins has had a major negative impact on its ecosystem. For example, the monthly DEX volume in Solana dropped to $92 billion in December from a peak of $313 billion. Its network fees has also plunged from $241 million in January to $15 million this month.
Additionally, Solana has experienced a sharp decline in futures open interest, which moved to $7.3 billion from the year-to-date high of over $16 billion.
Potential Catalysts for SOL Price in 2026
Solana price has numerous bullish catalysts in 2026. One of them is the ongoing SOL ETF accumulation. These funds had $199 million, $419 million, and $137 million in inflows in the last three months, bringing the total to $755 million.
They hold $926 million in assets, equivalent to 1.35% of its market cap. This means that these funds have more gains to go as Ethereum and Bitcoin multiples stand at over 5%.
Solana will also unveil the Alpenglow upgrade that will replace the proof-of-history (PoH) and TowerBFT with votor and rotor. Votor will handle fast and direct validator for block finalization, while rotor will have an improved data dissemination protocol.
There are also chances that the community will vote to reduce its inflation, which stands at 8% annually. It decreases by 15% annually, with the long-term goal of reducing it to 1.5%.
Some teams, especially Helium, have made a proposal to double the disinflation rate from 15% to 30%. The goal will be to reach the terminal rate of 1.5% in 3.1 years instead of 6.2 years.
Solana Price Technical Analysis
The three-day timeframe chart shows that the SOL price peaked at $296 in 2025 and then plunged to the current $124.57. A closer look shows that the token formed a head-and-shoulders pattern. It is now sitting at the neckline, which is along the 61.8% Fibonacci Retracement point.
Therefore, the most likely SOL price prediction is bearish, with the potential target being at $70.45, the 78.6% retracement level.
28
12, 2025
Feel Free customers say the kratom drink is making…
For two decades, 5-hour Energy, an energy drink sold in colorful two-ounce bottles in convenience store chains nationwide, has been the go-to booster for thousands of tired truckers and cramming college students. But last year, for the first time, it was reportedly surpassed as one major national convenience store chain’s top energy drink—by a product that had been on that chain’s shelves for only four months.
This up-and-coming brand, Feel Free, was marketing itself as something slightly different. As it declared in a white, scrolling font over the deep blue of its own two-ounce bottle, Feel Free was a “plant-based herbal supplement,” a proprietary blend of extracts from the botanicals kratom and kava, boasting properties that could amplify focus and boost mood.
For many users, however, the beverage didn’t have the advertised effect. Drew Barrett, of Champaign, Ill., says he was enticed by Feel Free’s serene packaging and its offer of relaxation and enhanced energy. But he soon found that after the immediate euphoria from the shot, he would be hit with a cycle of unpleasant symptoms, including a runny nose and achy body.
Still, the euphoria was real, and in a matter of months, Barrett says, he became addicted to the supplement. Barrett, 46, says he would down a two-ounce bottle of Feel Free 10 to 12 times a day—far surpassing the recommended dosage of one per day. At about $8 per bottle, the habit cost him about $2,000 a month; he bought so much that the local smoke shop where he was purchasing the bottles began giving him an employee discount. He lost 35 pounds; his eyes sunk into his head, and his skin took on a gray color. Barrett says he became so dependent on the drink he had to close down the thrift store he owned and seek in-patient treatment.
“The stuff is poison,” he told Fortune.
Barrett’s experience was alarming, but it isn’t unique: Complaints from aggrieved consumers are easy to find online, thanks in part to a range of viral social media posts. Those users share certain key concerns: that Feel Free’s marketing downplayed the fact that the drink contains kratom, creating problems for people who didn’t realize what they were ingesting.
Those dangers can be significant, according to multiple studies: Kratom is a psychoactive substance, and in larger doses it has been linked to seizures, high blood pressure, vomiting, liver damage, addiction, and hallucinations.
Indeed, in September 2024—the same month the product topped the sales charts at the convenience store chain—its manufacturer, Botanic Tonics, paid $8.75 million to settle a class-action lawsuit involving allegations that Feel Free’s labeling didn’t make clear just how much kratom is in each bottle, and had failed to alert consumers to the dangers of taking the substance in large quantities. (The company did not admit to any wrongdoing.) That settlement capped a tumultuous two-year stretch during which U.S. Marshals seized hundreds of thousands of bottles of Feel Free—and during which the founder of Botanic Tonics stepped down as CEO and publicly disclosed that he had formerly served federal prison time.
And yet, despite that chaos, the company’s business has continued to thrive. Today, Feel Free can be found in around 30,000 stores and counting, and has sold 130 million units, generating more than $250 million in annual sales and earning a steady profit for Botanic Tonics. During the second week of this October, Feel Free sales surpassed those of Red Bull and Monster Energy at a top-five convenience store chain, according to a Botanic Tonics press release citing Nielsen IQ data.
“Our product has the strongest safety record of any kratom product on the market, backed by government testing, clinical trials, and expert medical review,” a Botanic Tonics spokesperson told Fortune.
The company is working within the limits and at the edges of a hobbled American regulatory system that has largely looked away from the potential hazards in dietary supplements. The Food and Drug Administration, for its part, has a clear position on the substance: “Kratom is not appropriate for use as a dietary supplement,” its website says, adding that there’s insufficient information to prove that the substance is safe. But under lenient laws enacted in the 1990s, supplement manufacturers have incredible leeway to market their products—enabling them to operate in a legal gray area where consumer protections are few, and where sellers can be vague about ingredients and side effects, even when the potential for harm is serious.
“Feel Free is no different than any dietary supplement,” says Robert Durkin, former deputy director of the FDA office responsible for regulating dietary supplements, and now a lawyer who previously represented Botanic Tonics. “If it’s following the rules, it could legally be on the market.”
A powerful herb, an unusual founder
Kratom was largely unknown in the U.S. until a few decades ago, but it has always been associated with medicinal and psychoactive properties. As a minimally processed botanical usually served as a tea, kratom has been used for centuries as an analgesic and to treat ailments like cough and digestive issues—and, more recently, to aid those weaning off opiates. Indeed, Drew Barrett and other Feel Free users told Fortune they had previously used kratom as an attempt to alleviate other substance abuse issues.
Soren Shade, a kratom advocate and cofounder of kratom tea company Top Tree Herbs, says that the herb was likely brought stateside in the 1970s by Vietnam War veterans who had developed heroin habits while serving overseas, and were using kratom as a harm reduction tool. The leaf may also have come to America via Southeast Asian immigrants, who used and sold the plant within their communities.
The gradual loosening of restrictions against cannabis and cannabinoids helped make room in the market for other herbal and botanical products. By the time Botanic Tonics was founded in 2020, kratom products had become a $2 billion industry; according to one study, kratom was used by about 1.7 million Americans in 2021.
JW Ross, Botanic Tonics’ founder, has said he was inspired to launch the company by multiple trips to the South Pacific and Southeast Asia; he was determined to create an herbal supplement product that promoted what he envisioned as a healthy lifestyle, he said, particularly as he had struggled in the past with his own sobriety. One of the results, Feel Free, hit the market in 2020.
Sales skyrocketed, but so did consumer complaints. In April 2023, a class action lawsuit was filed in California against Botanic Tonics and a handful of retailers selling Feel Free, accusing them of fraud and false advertising.
The suit alleged that Botanic Tonics’ packaging did not disclose how much kratom was in Feel Free, or that Feel Free could have significant side effects. Plaintiffs claimed that Feel Free was marketed as a drink that could induce calmness and relaxation, and was no more habit-forming than caffeine—but that using the product had led many customers to become addicted to it. Lead plaintiff Romulo Torres had been hospitalized for symptoms including “vomiting, lapses in consciousness, delirium, and psychosis,” the lawsuit claimed. (Drew Barrett cited similar issues but was not one of the plaintiffs in the suit.)
According to the plaintiff, the class could have more than 5,000 members; Botanic Tonics said it has received fewer than 1,000 adverse event complaints from users. Still, the suit got results: In September 2024, Botanic Tonics agreed to the $8.75 million settlement.
As a result of the agreement, Botanic Tonics has improved product labeling “with clear warnings about potential effects and visible serving size indicators,” the company said. It also proactively raised the minimum purchase age for its products to 21. A company spokesperson told Fortune, “This product is not for people who have previously struggled with substance abuse and is only intended for healthy adults.”
Launching the company, it turns out, was part of a broader reinvention: About 15 years ago, Ross was living under a different legal name, Jerry Cash. As Cash, Ross was an oil and gas industry mogul in Oklahoma who was convicted in court and served federal prison time for failing to disclose the diversion of $10 million in corporate funds for personal uses. According to authorities, more than $5 million went toward renovating his Oklahoma City-area home.
Ross stepped down as CEO of Botanic Tonics in April 2024, while the class-action litigation was still ongoing; he was replaced by Cameron Korehbandi, who holds the role today. Ross disclosed his previous identity to investigative journalist Scott Carney in June 2024 and shared that he lived under a different identity in a letter on his website. Botanic Tonics did not respond when asked if Ross is still involved in its operations, and Ross did not respond to Fortune’s multiple interview requests.
Skepticism and pushback
The kratom Ross encountered in his travels to Southeast Asia was likely different from the substance packaged in Feel Free’s blue bottles, according to scientists who have studied the plant. When reprocessed as a powder or capsule, and in higher dosages, kratom has been associated with the swath of symptoms outlined in the 2023 class action lawsuit, leading some scientists to say that kratom in general is a potential public health threat.
For its part, Botanic Tonics has cited third-party research on the safety of Feel Free when taken at recommended dosages, saying those studies deemed Feel Free Classic Tonic to be safe with mild to moderate adverse events, including nausea, headaches, and fatigue for those in the highest-dose group of one bottle per day.
Ultimately, public health experts feel there isn’t enough research to determine whether the potential benefits of kratom outweigh the risks. “The regulatory market and research on its theoretic use hasn’t advanced enough at the same pace that [kratom] has become available as a supplement,” Silvia Martins, director of the Substance Use Epidemiology Unit at Columbia University Mailman School of Public Health, told Fortune.
Some politicians and jurisdictions have heard enough that they’ve made up their minds. In August, Ohio Gov. Mike DeWine called on the Ohio Board of Pharmacy to schedule kratom compounds as illegal drugs. Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin, and Washington, D.C. have banned the substance, and eight other states have set a legal age limit of 21 to buy products containing kratom.
The FDA also disapproves of kratom’s use, stating on its website, “FDA has concluded…that kratom is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.”
But despite that stance, the FDA has done little to restrict kratom. That’s due in large part, experts say, to the regulator having been essentially defanged about 30 years ago, creating what would become the Wild West of dietary supplements. “The agency has very weak enforcement powers, but most frequently, [doesn’t] even use the weak powers that they have,” Pieter Cohen, an associate professor of medicine at Harvard Medical School whose research is in dietary supplement safety, told Fortune.
The FDA did not respond to multiple requests for comment for this story.
The defanged FDA
For the better part of the 20th century, the FDA tried to classify dietary supplements as drugs, and later as food additives, in order to regulate products before they hit the market. In the late 1980s and early ‘90s, Congress even weighed a series of bills that would have strengthened the powers of the FDA, particularly in how it regulated product labels.
But those measures faced strident and well-financed pushback from the supplement industry. (One famous 1994 advertisement from a pro-supplement organization featured a fictional scene of actor Mel Gibson being arrested in his home by the FDA for taking vitamin C.) In October 1994, Congress passed the Dietary Supplement Health and Education Act (DSHEA), an amendment to the Federal Food, Drug, and Cosmetic Act that made it much easier for supplements to reach the market without having to demonstrate their safety or efficacy.
Ultimately, Congress justified DSHEA on the principle that customers should be informed, but also empowered with access to a marketplace of products with the potential to enhance their health. While the act outlines certain labeling practices a product must abide by, it does not require companies to gain—or even seek—FDA approval before a product hits the market, nor to prove the product is safe for human consumption. Instead, the FDA can take action against a product only once it finds sufficient evidence it is dangerous.
In practice, that’s a path the regulator will only pursue in extreme cases, such as where deaths are strongly linked to a product, said Marion Nestle, professor emerita of nutrition, food studies, and public health at New York University. DSHEA “was a total win for the industry,” Nestle told Fortune. “The public health community thinks it’s a travesty because there’s no federal guarantee that what’s in the product is what the product says it has.”
Indeed, with little risk of being taken off the market, supplement companies have taken liberties with even the skeletal labeling framework outlined by DSHEA. A 2023 analysis of 57 sports supplements, conducted by Harvard professor Cohen, found 89% of the products failed to accurately label their contents by FDA standards.
A seizure, but no ban
While FDA actions against supplement-makers are rare, the agency has taken at least one action against Feel Free. In May 2023, FDA investigators and U.S. Marshals seized more than 250,000 units of kratom-containing bottles along with other Feel Free products, a haul worth a total of more than $3 million, from Botanic Tonic’s production facility in Broken Arrow, Okla. The seizure, which came after a routine inspection, followed a forfeiture complaint filed on behalf of the FDA by federal prosecutors: The complaint claimed Feel Free was a “new dietary ingredient,” and that there was not enough information about the product to determine it was not dangerous to consume.
The seizure appears to have been related to bureaucratic slip-ups rather than safety complaints.
The FDA requires distributors and manufacturers of dietary supplements to submit a “new dietary supplement notification” if their product was not on the market prior to the passage of DSHEA. Even today, no new dietary ingredient notification from Botanic Tonics appears on the FDA’s list of submitted notifications, and the company did not respond to Fortune’s inquiry about whether the company has submitted a notification.
But despite the seizure, Botanic Tonics did not stop operations—because the FDA did not have a necessary injunction to stop production or prevent the product from reaching the market. Moreover, the court case is still ongoing. Weeks after the seizure, Botanic Tonics filed a motion to dismiss the forfeiture order and submitted a counterclaim, asserting its products should be returned to the company and that the government does not have enough proof to say that Feel Free is adulterated or misrepresented, or that it contains a new dietary ingredient with not enough research to deem it safe. On Dec. 10, a federal court judge assigned to the case last month denied Botanic Tonics’ motion to dismiss the case. The company declined to comment on the matter, as it is an ongoing action.
What’s in Feel Free?
Beyond the FDA’s misgivings, industry experts and public health professionals have questions about Botanic Tonics’ labeling practices, with some sources alleging the company has violated regulations around what is required on a label.
Feel Free is one of a handful of kratom products that uploaded its label to the National Institutes of Health’s Dietary Supplement Label Database of more than 200,000 labels. The product label currently available in the database dates to 2022, before the Feel Free class-action settlement.
Paul Coates, the former longtime director of the Office of Dietary Supplements at the NIH, which conducts research to inform regulation, reviewed the label at Fortune’s request, and said he still has his doubts—chiding the product for not spelling out on the label exactly what it contains. In particular, Coates called out Feel Free’s proprietary blend, which he describes as “2,600 milligrams of goop.”
“They talk about potassium, iron, and 2,600 milligrams of a proprietary blend that includes kratom alkaloids—25 milligrams—and kavalactones from kava root—250 milligrams,” Coates said. “That tells me that there’s an awful lot more in that 2,600 milligrams.” A full bottle of Feel Free is one fluid ounce, or about 29,500 milligrams.
Botanic Tonics has posted up-to-date labels for Feel Free products on its website that differ from what is uploaded to the label database, but Coates’ observation still stands: The label for Feel Free Classic does not contain information about the total amount of kava root extract or ground kratom leaf in each bottle, a requirement in the FDA’s nutrition labeling of dietary supplements.
Coates said Feel Free is hardly unique in the dietary supplement industry, where there’s little fact checking to ensure what is in the product matches what is on the label. “Unless you know what to look for, you can’t measure it,” Coates said. “I don’t have any idea how that’s broken down any further, and it’s probably not. There are no standard methods for measuring, and that is part of the problem.”
Botanic Tonics said it has undergone multiple certifications and clinical trials to verify that Feel Free Classic labels match what is in the product. It added that the kratom leaf and kava root in its product are manufactured in an FDA-registered facility and that Feel Free contains no kratom extract, concentrates, or synthetic ingredients.
A search for transparency
Ashley Snider, 34, wants kratom products to be more strictly regulated. Snider used to work at a supplement store and was introduced to Feel Free after a company representative dropped off sample products at her workplace. Soon, she says, she was spending $105 per month on a 12-pack subscription box of Feel Free—and then driving to a nearby convenience store to pick up more, sometimes taking six per day.
Snider told Fortune Feel Free made her continuously ill, and that she has not used it in nine months. When she cancelled her subscription, Snider said, the company sent her a pamphlet of mocktail recipes one can make using Feel Free. (Botanic Tonics denies that this book had been positioned as a cocktail or mocktail recipe book, stating rather that it was simply a book of recipes, and said Snider may have received the recipe book because it was mailed prior to her unsubscribing from the company. The company has a list of recipes on its website containing Feel Free products, none of which contain alcohol.)
What concerned Snider most, she said, was that while there are warnings about serving sizes on Botanic Tonics’ website (added to the brand’s label in 2022, according to the company), there were no guardrails in place that prevented her from ordering the product in much larger quantities than were recommended on the label. Botanic Tonics said its website is age-gated, required users to confirm they are over 21, and that one-third of its site is dedicated to consumer education. It did not say whether there are preventative measures on ordering a certain amount of product.
“I would like for there to be more transparency,” Snider told Fortune. “There needs to be something that separates them from just being readily available at gas stations, at supplement shops, not having reps go around and handing it out like Halloween candy.”
Even if the FDA were to crack down on Feel Free, other kratom beverage-makers could easily take its place in the market. The FDA makes assessments of a product’s safety based on health outcomes from that particular product’s dosage or blend of ingredients. In an industry with no standardized dosages for products, the FDA would be unable to generalize a takedown of one company to the whole industry.
“They might have to address it on this company-by-company basis. And that’s very inefficient,” said Cohen, the Harvard Medical School professor. “So fundamentally, we’re going to need to have a reform of the law…and I don’t see that in the near future.”
Industry experts tell Fortune there is little likelihood of regulatory changes under the current administration. In the leadup to the 2024 presidential election, Robert F. Kennedy Jr. vowed to end the “aggressive suppression” of dietary supplements and vitamins; Kennedy is now the secretary of Health and Human Services, with jurisdiction over the FDA.
The current enforcement system isn’t just inefficient, said Shade, the kratom advocate; it’s dangerous. If the FDA were to ban a particular alkaloid or compound in kratom demonstrated to be harmful, there’s nothing stopping a company from finding another alkaloid, just barely distinguishable from its prohibited predecessors, and sticking it on the market. Meanwhile, it typically takes the bureaucracy about a year to catch up and ban any given product, enough time for a new one to pop up on the market.
“It is an infinite game of Whack-a-Mole,” Shade said, “where every mole that pops up ends up being more unknown, more potent, and potentially more toxic.”
28
12, 2025
Top Meme Utility Tokens vs. Traditional DeFi Winners-Pepeto’s
Crypto news today reveals decentralized finance leaders still owning the volume on-chain while meme tokens continue to snatch the virality of retail liquidity.
These two narratives are now falling together. Traders are finding comfort in projects that blend the DeFi tool’s credibility with the meme culture’s reach.
This hybrid narrative, historically speaking, has produced the greatest cycles of upside. Pepeto (https://pepeto.io) is proving to be the outstanding meme utility ecosystem placed squarely in this mixed narrative advantage window.
DeFi Leaders Still Have a Stake in Market Volume
Bitcoin news today and Ethereum news today show steady growth among major protocols in DeFi. Projects like Aave, Uniswap, MakerDAO, Lido, Curve, and Compound continue to process billions of trading and lending volume.
These platforms offer stability and infrastructure, but their high market capitalizations cap percentage upside for new entrants. While DeFi remains fundamental, retail traders are also looking past the established platforms to hybrid ecosystems that can offer faster repricing cycles and greater asymmetry.
Why Meme Tokens Have Viral Liquidity
Meme tokens are all about the narrative velocity, the community, and social amplification of the narrative. SHIB, DOGE, PEPE, and BONK showed that viral liquidity can outperform basics during strong market phases.
However, models of pure memes have problems with sustainability. Once the hype cools down, liquidity tends to vanish. This creates demand for meme ecosystems that are also capable of providing real trading capabilities, staking systems, and infrastructure that can retain users beyond hype cycles.
Pepeto’s Hybrid Meme-DeFi Architecture
Pepeto operates on the Ethereum mainnet, and PepetoSwap, Pepeto Bridge (https://pepeto.io/#bridge) , Pepeto Exchange, and high-yield staking systems are already live. All the paths of ecosystem activity pass through $PEPETO, and the trading participation is transformed into direct token demand.
Pepeto is an audited company with SolidProof (https://pepeto.io/assets/documents/audit-solidproof.pdf) and Coinsult. Its staking system provides an APY of around 216% and locks up circulating supply in exchange for rewarding early participation. With the total supply a fixed 420 trillion tokens, staking alleviates sell pressure with routed ecosystem volume compounding demand.
How Pepeto Is Better than Traditional DeFi and Pure Meme Models
Traditional DeFi protocols have stability and little asymmetry. Pure meme tokens provide for asymmetry but poor retention. Pepeto blends both models. It is a combination of meme virality and DeFi-style retention loops through swap, bridge, exchange, and staking activity. This provides a continuous cycle in volume, which reinforces the same token rather than spreading liquidity over a number of assets.
Hybrid Narrative Market Psychology
Hybrid ecosystems have the advantage of having both social velocity and functional retention. Viral exposure helps attract new users, while DeFi-style tools keep people active within the same ecosystem. This dual-layer psychology is historically responsible for creating longer cycles of expansion and higher terminal valuations. Pepeto’s unified routing model ensures that all swaps, bridges, and trades compound demand back into one token, making the valuation more resilient.
Institutional Interest Versus Retail Spillover
Hybrid ecosystems also invoke institutional curiosity once retail traction is made visible. Funds are frequently following retail narratives, which exhibit viral engagement in addition to actual infrastructure.
Meme utility ecosystems that already have an audited trading stack in place can absorb this secondary liquidity much more efficiently than roadmap-only projects. Pepeto’s audited stack, unified routing, and staking-based supply controls put them in an ideal position to capture these spillover waves.
Presale Momentum & Community Growth
Pepeto’s community has passed 100,000 members. Presale participation has surpassed $7.12 million raised, and the current presale price is locked at 1 $PEPETO equal to $0.000000174. These metrics are indicative of accelerating early adoption while valuation is still early in comparison to established DeFi leaders.
Market history indicates that narrative hybrids are superior to single-theme projects. The future winners will be those who will combine emotional reach with structural retention. Pepeto is located precisely within this hybrid narrative window. It offers meme culture, real DeFi tools, and audited infrastructure in a unified demand engine.
How to Buy Pepeto
The Pepeto presale is live on the official website, https://pepeto.io . Buyers can link their wallet and buy with ETH, USDT, BNB, or credit card via Web3Payments. For early buyers, they can stake now to earn high APY before exchange listings. A giveaway worth $700,000 is also available on the official site.
An Aggressive Hybrid Conclusion
Pure DeFi limits upside. Pure memes have no sustainability. Pepeto delivers both. With audited contracts, live trading tools, staking supply locks, and an exponentially growing community, Pepeto is one of the strongest hybrid narrative opportunities of the next cycle.
Each presale stage that closes increases the costs of entry and eliminates supply. Traders scanning crypto news today for the next 100x meme coin and the best crypto to buy now and the best meme coin to buy are standing in front of one of the most structurally complete early-stage meme utility ecosystems left in this market.
To stay ahead of key updates, listings, and announcements, follow Pepeto on its official channels only:
Website: https://pepeto.io
X (Twitter): https://x.com/Pepetocoin
Telegram: https://t.me/pepeto_channel
Instagram: https://www.instagram.com/pepetocoin/
Repricing begins long before it becomes visible.
Contact: Dani Bonocci
Website: https://www.tokenwire.io
Phone: +971586738991
SOURCE: Pepeto
Press release distribution
This release was published on openPR.
28
12, 2025
Post-Regulatory Rally Potential and Why
In case of crypto news today, XRP is once again in focus as traders assess legal headlines and institutional demand signals while also considering the technical levels that often make up the next breakout phase. XRP has historically been a bursty token, especially when regulatory stories are moving from uncertainty to clearer pathways.
At the same time, cycle history indicates that once big caps have settled down, speculative capital begins to look for faster percentage upside. That is why Pepeto (https://pepeto.io) is appearing in the same conversations as a meme utility presale built on Ethereum, designed to capture the high beta rotation phase rather than compete with XRP’s role as a steadier core holding.
XRP Market Context and Regulatory Execution
On CoinMarketCap, XRP’s current price is $1.87 with a live market cap at $113,418,576,486 and a 24-hour trading volume of about $1,027,643,065. XRP is not treated like a lottery ticket for micro caps with deep liquidity. In the broader backdrop, Bitcoin is about $87,775.13 with a market cap near $1,752,700,964,841, and Ethereum is about $2,945.10 with a market cap near $355,458,532,264. The larger the base is, the more difficult it is to provide extreme multiples quickly.
Regulatory narrative remains a catalyst, and 2025 coverage has repeatedly linked XRP’s momentum to court process milestones and the likelihood of clearer outcomes that could open wider institutional comfort.
Even in the case of mixed headlines, the market has increasingly come to value XRP as a cleaner risk than in previous years. Still, given that XRP is already a major asset, more realistic expectations are often more moderate growth rather than explosive 50x moves.
Technical Analysis Using Multiple Indicators
A technical view assists the conversion of a narrative into levels. First is trend. Traders watch the 50-day moving average as the pivot point and the 200-day moving average as the cycle baseline. If XRP is supported above the 200-day line and the 50-day line begins to turn up, it is often an accumulation sign rather than one of breakdown.
Second is momentum. RSI near the middle is normal for ranges, but higher RSI lows in sideways price action can provide a clue to underlying bid strength. MACD can verify such a shift when the histogram narrows and the bullish cross is formed.
Third is Volatility and Confirmation. Bollinger Bands constriction indicates compression. A definitive close outside the bands, combined with increasing volume, is often the trigger traders consider to be a key breakout. XRP’s chart setup usually rewards patience, given the fact that the strongest rallies begin after long consolidations.
Why Diversifying Into Pepeto Can Improve Upside
That profile is why it can make sense to diversify into a high-risk, high-reward sleeve. XRP can serve as a core position for investors who desire liquidity and exposure to any regulatory tailwind repricing. Pepeto is framed as the portfolio multiplier option for traders targeting the next meme coin to explode.
Pepeto runs on the Ethereum mainnet and blends meme culture with real utility. It includes PepetoSwap as a zero-fee swap layer, Pepeto Bridge for cross-chain movement, and Pepeto Exchange as a verified meme exchange where all volume routes through $PEPETO, turning usage into token demand. Pepeto emphasizes staking APY around 216% (https://pepeto.io/en/staking) to encourage holding and reduce near-term circulating supply, with audits by SolidProof and Coinsult for credibility.
The presale snapshot lists 1 PEPETO at $0.000000174, with a fixed 420T supply (https://pepeto.io/#tokenomics) , more than 100,000 community members, and more than $7 million raised so far. The ecosystem story also references 850-plus projects applying to participate, which supports the routed volume demand thesis. This is why many buyers treat Pepeto as the best crypto presale to buy when hunting asymmetric meme cycle upside.
How to Buy Pepeto
The Pepeto presale is active at (https://pepeto.io) . Before you connect your wallet to a website, verify the official domain to avoid fake sites. Connect your wallet and then purchase with ETH, USDT, or BNB or using your bank card via Web3Payments.
Confirm the purchase at the current presale price of $0.000000174 per PEPETO, then consider staking immediately to access the high APY window before launch. The official website also promotes a $700,000 giveaway, so stay in all official channels and ignore random links shared in replies or group chats.
Conclusion
XRP’s post-regulatory rally potential is real since clearer frameworks have historically been great combinations for big caps with big depth of liquidity. Technically it’s all about confirmation, holding support and building momentum back up, and then breaking resistance and volume after volatility compression. That profile makes XRP a good candidate to be a core holding.
The thesis of upside acceleration is usually captured elsewhere. When large caps are stabilizing, rotation flows often follow higher beta opportunities. Pepeto is positioned for that phase with an Ethereum-based meme utility stack, audited contracts, staking-driven supply tightening, and routed ecosystem volume that can translate activity into token demand.
If you are scanning crypto market news today for the best meme coin to buy now, the regret trade often is waiting until after listings and mainstream coverage. Pepeto is still in the presale window, and that is where the asymmetry lives.
To stay ahead of key updates, listings, and announcements, follow Pepeto on its official channels only:
Website: https://pepeto.io
X (Twitter): https://x.com/Pepetocoin
Telegram: https://t.me/pepeto_channel
Instagram: https://www.instagram.com/pepetocoin/
Quiet markets provide room to build without pressure.
Contact: Dani Bonocci
Website: https://www.tokenwire.io
Phone: +971586738991
SOURCE: Pepeto
Press release distribution
This release was published on openPR.
28
12, 2025
Unveiling the ki’en Matcha Club Experience Center & Café in Gurugram, ETHospitalityWorld
ki’en Matcha Club announced the grand opening of its flagship ki’en Matcha Club Experience Center & Cafe, a unique destination designed to deepen the public’s understanding and enjoyment of authentic Japanese matcha in Gurugram. The venue moves beyond the standard cafe model to offer a holistic immersion into the world of this revered green tea.
More than just a cafe, the center invites guests to explore matcha’s rich history and craftsmanship where customers can go through the journey of matcha, from the shaded tea fields of Japan to the stone-grinding process that creates its fine powder.
More than just a cafe, the center invites guests to explore matcha’s rich history and craftsmanship where customers can go through the journey of matcha, from the shaded tea fields of Japan to the stone-grinding process that creates its fine powder. Additionally, it also offers traditionally prepared ceremonial-grade matcha, modern matcha-infused beverages, and curated pastries in a serene setting, said a release.
The space is divided into two interconnected areas, a tranquil cafe and an interactive educational zone, with a carefully crafted menu featuring vibrant, whisked-to-order ceremonial matcha, alongside contemporary lattes and a selection of desserts that highlight matcha’s complex flavor profile.
A key feature is the interactive experience zone, where people can learn about matcha’s origins, its meticulous production, and the nuances of different grades directly from our specialists.
“From the beginning, we envisioned a space that respects matcha’s deep history but welcomes everyone. People are asking more questions about where their matcha comes from and what makes it special. This centre is our response that comes with a place to explore through your senses, to understand the difference real ceremonial matcha makes. We’re inviting our guests to pause and discover the craft behind the cup,” said Damini Guglani, co-founder of the ki’en Matcha Club Experience Centre & Café.
The design of the center reflects a Japanese aesthetic of simplicity and natural materials, creating a calm atmosphere focused on mindful consumption, the release added.
28
12, 2025
What qualifies as tea, according to FSSAI? Tips to make the right purchase | Health
The latest directive on tea applies to producers, importers, and e-commerce platforms. Photo: AI-Generated image
The Food Safety and Standards Authority of India (FSSAI) recently issued a directive stating that only beverages derived from the Camellia sinensis plant can be labelled as tea. The authority aims to prevent unfair labelling practises that could mislead consumers. The FSSAI has issued this directive amid brands introducing teas in various flavours.
Drinks that are brewed with flowers, spices or herbs are often labelled as tea. However, the FSSAI has discovered that these drinks are not derived from the real tea plant. FSSAI recommends that green tea, Kangra tea, and instant tea should be prepared from Camellia sinensis. The latest directive applies to producers, importers, and e-commerce platforms. The authority warns that strict action would be taken against brands that label drinks brewed from spices or other plants as tea for misbranding.
FSSAI warns that strict action would be taken against brands that label drinks brewed from spices or other plants as tea for misbranding.. Photo: iStock/tashka2000
How to buy safe, healthy tea?
According to the Food Safety and Standards Authority of India, only pure, plant-derived tea, which is traditionally prepared and minimally processed, qualifies as tea. They should not contain artificial colours, contaminants, or adulterants. While purchasing tea powder from stores, customers can also check the ingredient list on the packet to see whether ‘tea’ or ‘camellia sinensis’ is listed. Also, examine whether it is written whether the tea is flavoured and whether it mentions its types, such as green, black, Kangra, or instant tea. Details on standards, labelling and ingredients are also available here.
onmanorama-topic-general-topics-18-healthcare onmanorama-topic-general-topics-76-health 5ikh085dcfk9isrlqjjrdp7qp5-list 2trecsdir9ob82bltokdekl46d 5b9vsielt2dvr4lg8lebt6qted-list onmanorama-topic-organisation-3-food-safety-and-standards-authority-of-india-